Recap: Fair Isaac Q1 Earnings

Fair Isaac (NYSE:FICO) reported its Q1 earnings results on Thursday, January 25, 2024 at 04:15 PM. Here’s what…

Fair Isaac (NYSE:FICO) reported its Q1 earnings results on Thursday, January 25, 2024 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

Fair Isaac missed estimated earnings by 4.94%, reporting an EPS of $4.81 versus an estimate of $5.06.

Revenue was up $37.19 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.2 which was followed by a 2.37% increase in the share price the next day.

Here’s a look at Fair Isaac’s past performance:

Quarter Q4 2023 Q3 2023 Q2 2023 Q1 2023
EPS Estimate 5.21 5.25 4.06 4.18
EPS Actual 5.01 5.66 4.78 4.26
Revenue Estimate 389.42M 381.81M 373.18M 344.29M
Revenue Actual 389.73M 398.69M 380.27M 344.87M

To track all earnings releases for Fair Isaac visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And ‘Substantial Growth’

Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its first quarter financial results for the three months ended March 31, 2024. The Toronto-based company reported a total revenue of CA$16.4 million ($12 million) (net revenue of CA$12.7 million, before excise duties and discounts), representing a 9% year-over-year increase. "Entourage's first quarter results are a testament to our robust financial health and strategic approach to business operations, positioning us for success throughout 2024," George Scorsis, the company's chair and CEO, said. "With defined infrastructure and supply agreements in place, we are well-positioned to continue delivering the accelerated growth we have already seen develop in Q1."

ETRGF